Genesys Teams up With Agfa Spinoff

Article

PACS firm Genesys and compact video camera manufacturer VisiplexInstruments have inked a joint marketing agreement to sell eachother's products on a global basis. The new alliance was evidentat last month's RSNA meeting, where Visiplex demonstrated

PACS firm Genesys and compact video camera manufacturer VisiplexInstruments have inked a joint marketing agreement to sell eachother's products on a global basis. The new alliance was evidentat last month's RSNA meeting, where Visiplex demonstrated Genesysproducts at its booth.

The agreement is good way for both companies to play off eachother's strengths when competing with larger firms, accordingto William Greenblatt, Genesys vice president of sales.

"Even with a PAC system, you still need output peripherals,"Greenblatt said. "Genesys is a smaller company, and it makessense for us to diversify."

Visiplex was formed last July when executives at Agfa's Orangeburg,NY, facility purchased the former Matrix compact camera businessfrom Agfa (SCAN 7/14/93).

Since the purchase, Visiplex has introduced two new compactcameras. CCM601 is an ultrasound camera in both gray-scale andcolor for 4 on 1 and 6 on 1 formats. CCM650 is an ultra-high-resolutioncamera for nuclear medicine and C-arm applications. Both camerashave Food and Drug Administration marketing clearance.

Genesys, of Orlando, FL, displayed new MRI viewing softwareat the Visiplex booth. The works-in-progress software runs onan Imlogix workstation and enables clinicians to view MRI slicessimultaneously. Genesys purchased Imlogix in 1992 (SCAN 12/30/92).

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
Diagnostic Imaging’s Top Five Breast Imaging Content: Summer 2025
Reducing Mammography Workload by Nearly 40 Percent? What a New Hybrid AI Study Reveals
 What New Research Reveals About Portable Low-Field MRI and Patients with Suspected Alzheimer’s Disease
© 2025 MJH Life Sciences

All rights reserved.